HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

RIFM-Led Study Shows QRA Is Effective

You may also be interested in...



IFRA Works To Block Legislation Limiting Fragrance Ingredients

The trade group seeks to prevent the European Commission from passing legislation recommended by the Scientific Committee on Consumer Safety to strongly limit the use of certain fragrance ingredients. IFRA’s work plan seeks to address fragrance contact allergy without establishing such limits.

RIFM, European Scientists Work To Iron Out Differences On QRA Methodology

The Research Institute for Fragrance Materials is in talks with industry representatives and European scientific authorities regarding its quantitative risk assessment (QRA) approach to fragrance sensitization, which has been received with varying degrees of enthusiasm

Lumi-Cell Endocrine Disruptor Test Validation Supported By ICCVAM

Validation of the stably transfected recombinant cell based estrogen receptor transcription method should be designated a high priority to assess its usefulness as an in vitro assay to detect substances with in vitro ER agonist and or ER antagonist activity, the Interagency Coordinating Committee on the Validation of Alternative Methods recommended

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel